---
figid: PMC9642324__goac061f1
pmcid: PMC9642324
image_filename: goac061f1.jpg
figure_link: /pmc/articles/PMC9642324/figure/goac061-F1/
number: Figure 1
figure_title: ''
caption: 'Thiopurine metabolism and proposed mechanisms of action. Green boxes indicate
  three immunosuppressing effects of thiopurines: TdGTP intercalation into DNA, inhibition
  of Rac1 and subsequent T-cell activation, and inhibition of de novo DNA synthesis.
  Red lines indicate inhibition of XO by allopurinol (can be used to shunt the pathway
  away from 6-TU in patients with high TPMT activity receiving low-dose thiopurines).
  AZA, azathioprine; 6-MP, 6-mercaptopurine; 6-TG, 6-thioguanine; 6-TU, 6-thiouric
  acid; 6-TIMP, 6-thioinosine monophosphate; 6-TXMP, 6-thioxanthine monophosphate;
  6-TGMP, 6-thioguanine monophosphate; 6-TGDP, 6-thioguanine diphosphate; 6-TGTP,
  6-thioguanine triphosphate; TdGTP, deoxy-thioguanosine triphosphate; TdGMP, deoxy-thioguanosine
  monophosphate; 6-MMP, 6-methylmercaptopurine; Rac1, Ras-related C3 botulinum toxin
  substrate 1; 6-MMPR, 6-methylmercaptopurine ribonucleotides; TPMT, thiopurine methyltransferase;
  NUDT15, nucleoside diphosphate-linked moiety X-type motif 15; XO, xanthine oxidase;
  HGPRT, hypoxanthine-guanine phosphoribosyl transferase; GMPS, guanosine monophosphate
  synthetase; IMPDH, inosine monophosphate dehydrogenase; GAP, GTPase-activating protein.
  This figure was adapted from [], and subsequently revised and updated.'
article_title: 'Immunomodulators: still having a role?.'
citation: Jeffery M Venner, et al. Gastroenterol Rep (Oxf). 2022;10:goac061.
year: '2022'

doi: 10.1093/gastro/goac061
journal_title: Gastroenterology Report
journal_nlm_ta: Gastroenterol Rep (Oxf)
publisher_name: Oxford University Press

keywords:
- immunomodulators
- 6-mercaptopurine (6-MP)
- azathioprine
- Crohnâ€™s disease
- methotrexate

---
